-transparent.png){kind=logo}
The absorption of erythromycin in infants and children was estimated after the administration of an erythromycin suspension. The subjects were divided into 3 age groups: 0-1 month, 1-6 months and 6 months-6 years. The absorption was lower in infants less than 1 month of age than in the older children. Erythromycin ethylsuccinate and erythromycin stearate were equally well absorbed in the fasting state in subjects 6 months-6 years of age. Administration of the drug at mealtimes considerably increased the absorption of erythromycin ethylsuccinate but had little effect on the absorption of erythromycin stearate. The absorption of erythromycin stearate in the fasting state was much lower than that of erythromycin ethylsuccinate in infants 1-6 months of age. None of the infants given erythromycin ethylsuccinate because of an outbreak of whooping-cough on the neonatal ward showed evidence of liver toxicity, nor did they develop symptoms of whooping-cough.
M Eriksson, and
P Bolme, and
M Blennow
May 1954,
The Journal of pediatrics,
M Eriksson, and
P Bolme, and
M Blennow
January 1986,
Pediatric infectious disease,
M Eriksson, and
P Bolme, and
M Blennow
November 1989,
Acta paediatrica Scandinavica,
M Eriksson, and
P Bolme, and
M Blennow
November 1987,
Antimicrobial agents and chemotherapy,
M Eriksson, and
P Bolme, and
M Blennow
May 1983,
Antimicrobial agents and chemotherapy,
M Eriksson, and
P Bolme, and
M Blennow
July 1979,
Antimicrobial agents and chemotherapy,
M Eriksson, and
P Bolme, and
M Blennow
September 1953,
Antibiotics & chemotherapy (Northfield, Ill.),
M Eriksson, and
P Bolme, and
M Blennow
June 1958,
Nutrition reviews,
M Eriksson, and
P Bolme, and
M Blennow
January 1953,
Antibiotics & chemotherapy (Northfield, Ill.),
M Eriksson, and
P Bolme, and
M Blennow
November 1992,
Antimicrobial agents and chemotherapy,
